Company Filing History:
Years Active: 2001-2004
Title: Graham Henry Farrar: Innovator in Microencapsulation Technology
Introduction
Graham Henry Farrar is a notable inventor based in Salisbury, GB. He has made significant contributions to the field of biotechnology, particularly in the area of microencapsulation for vaccination and gene therapy. With a total of 6 patents to his name, Farrar's work has the potential to impact medical treatments and vaccine delivery systems.
Latest Patents
Farrar's latest patents include innovative methods for creating microencapsulated DNA. One of his key inventions is a method of making a microparticle that contains DNA coding for a polypeptide. This method utilizes a solvent extraction technique at elevated temperatures, allowing for the oral administration of the microparticle, which leads to its expression. The DNA incorporated into the microparticle is designed to stimulate antibody formation in recipients, as well as to serve gene therapy applications without compromising its functionality.
Another significant patent focuses on microencapsulated DNA for vaccination and gene therapy. This microparticle also contains DNA coding for a polypeptide, and its oral administration results in expression. The dual purpose of the DNA—stimulating antibody formation and serving non-immunogenic polypeptide functions—highlights the versatility of Farrar's innovations.
Career Highlights
Throughout his career, Farrar has worked with esteemed organizations such as the Microbiological Research Authority and the Health Protection Agency. His experience in these institutions has allowed him to develop and refine his groundbreaking technologies.
Collaborations
Farrar has collaborated with notable colleagues, including David Hugh Jones and James Christopher Stephen Clegg. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Graham Henry Farrar's contributions to microencapsulation technology represent a significant advancement in the fields of vaccination and gene therapy. His innovative methods and collaborative efforts continue to pave the way for future developments in biotechnology.